Clever Leaves Holdings Inc. (CLVR)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Clever Leaves Holdings Inc. (CLVR) with AI Score 47/100 (Weak). Clever Leaves Holdings Inc. is a global cannabis company operating through cannabinoid and non-cannabinoid segments. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 16, 2026Clever Leaves Holdings Inc. (CLVR) Healthcare & Pipeline Overview
Clever Leaves Holdings Inc., founded in 2017, operates in the global cannabis market, focusing on cannabinoid and non-cannabinoid products. With a presence in both international cannabinoid markets and the U.S. nutraceutical sector, the company faces challenges typical of the evolving cannabis industry, including regulatory hurdles and intense competition.
Investment Thesis
Investing in Clever Leaves Holdings Inc. presents a high-risk, high-reward scenario. The company operates in the rapidly evolving cannabis industry, offering potential for significant growth but also exposing investors to substantial risks. Key value drivers include the expansion of its international cannabinoid operations and the growth of its nutraceutical business in the U.S. However, the company's negative profit margin of -102.8% and OTC market listing raise concerns about its financial stability and liquidity. Growth catalysts include potential regulatory changes in key markets and successful product launches. Investors should carefully consider the company's financial position, competitive landscape, and regulatory environment before investing. The high beta of 4.48 indicates significant volatility.
Based on FMP financials and quantitative analysis
Key Highlights
- Clever Leaves operates in the Cannabinoid segment, focusing on cultivation, extraction, and distribution of cannabis products internationally.
- The company's Non-Cannabinoid segment formulates and sells nutraceuticals and wellness products in the United States.
- Clever Leaves was founded in 2017 and is based in Boca Raton, Florida.
- The company has a gross margin of 37.6%.
- Clever Leaves has 296 employees.
Competitors & Peers
Strengths
- Diversified product portfolio (cannabinoid and non-cannabinoid).
- International presence in key cannabis markets.
- Established distribution network in the U.S. nutraceutical market.
- Expertise in cannabis cultivation and extraction.
Weaknesses
- Negative profit margin.
- High beta indicating significant volatility.
- OTC market listing raises liquidity concerns.
- Dependence on regulatory changes in the cannabis industry.
Catalysts
- Upcoming: Potential regulatory changes in key international markets could open new opportunities for cannabinoid product sales.
- Upcoming: Successful product launches in the U.S. nutraceutical market could drive revenue growth.
- Ongoing: Expansion of the company's distribution network in the United States.
- Ongoing: Strategic partnerships and acquisitions to expand market reach.
- Ongoing: Research and development efforts to create innovative and differentiated products.
Risks
- Ongoing: Evolving and uncertain regulatory landscape in the cannabis industry.
- Ongoing: Intense competition in both the cannabis and nutraceutical markets.
- Potential: Fluctuations in commodity prices could impact profitability.
- Potential: Product recalls or liability claims could damage the company's reputation and financial performance.
- Potential: Limited access to capital due to OTC market listing.
Growth Opportunities
- Expansion of Cannabinoid Operations: Clever Leaves has the opportunity to expand its cannabinoid operations in international markets. As more countries legalize cannabis for medicinal or recreational use, the company can leverage its existing infrastructure and expertise to enter new markets and increase its market share. The global cannabis market is projected to reach $57 billion by 2027, offering significant growth potential for Clever Leaves.
- Growth in the U.S. Nutraceutical Market: The company can capitalize on the growing demand for nutraceuticals and wellness products in the United States. By expanding its product portfolio and distribution network, Clever Leaves can increase its sales and market share in this segment. The U.S. nutraceutical market is estimated to be worth $80 billion, providing a substantial opportunity for Clever Leaves.
- Strategic Partnerships and Acquisitions: Clever Leaves can pursue strategic partnerships and acquisitions to expand its capabilities and market reach. By partnering with other companies in the cannabis or nutraceutical industries, the company can gain access to new technologies, products, and markets. Acquisitions can also help Clever Leaves consolidate its position in key markets and increase its economies of scale.
- Product Innovation and Differentiation: Clever Leaves can invest in research and development to create innovative and differentiated products that meet the evolving needs of consumers. By developing unique formulations and delivery methods, the company can gain a competitive advantage and increase its brand recognition. This includes exploring new cannabinoid-based therapies and novel nutraceutical products.
- Regulatory Changes and Market Liberalization: Changes in regulations and market liberalization can create new opportunities for Clever Leaves. As more countries and states legalize cannabis, the company can expand its operations and access new markets. Monitoring and adapting to regulatory changes will be crucial for Clever Leaves to capitalize on these opportunities. This includes advocating for favorable regulations and participating in industry discussions.
Opportunities
- Expansion into new international cannabis markets.
- Growth in the U.S. nutraceutical market.
- Strategic partnerships and acquisitions.
- Product innovation and differentiation.
Threats
- Evolving and uncertain regulatory landscape.
- Intense competition in the cannabis and nutraceutical industries.
- Fluctuations in commodity prices.
- Potential for product recalls or liability claims.
Competitive Advantages
- International presence in the cannabinoid market.
- Diversified product portfolio across cannabinoid and non-cannabinoid segments.
- Established distribution network in the United States.
- Expertise in cannabis cultivation and extraction.
About CLVR
Clever Leaves Holdings Inc., established in 2017, is a cannabis company headquartered in Boca Raton, Florida. The company operates through two primary segments: Cannabinoid and Non-Cannabinoid. The Cannabinoid segment is involved in the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products on a global scale. This includes various cannabis-derived products targeted at medicinal and wellness applications. The Non-Cannabinoid segment focuses on the formulation, manufacturing, marketing, selling, and distribution of nutraceuticals, natural remedies, wellness products, detoxification products, and nutritional and dietary supplements. These products are primarily sold to mass retailers, specialty and health retailers, and distributors within the United States. Clever Leaves aims to leverage its international presence and diversified product portfolio to capture a significant share of the growing cannabis and wellness markets. However, the company faces challenges related to regulatory complexities, market competition, and achieving profitability.
What They Do
- Cultivates cannabis plants for cannabinoid extraction.
- Extracts cannabinoids from cannabis plants.
- Manufactures cannabinoid-based products.
- Commercializes and distributes cannabinoid products internationally.
- Formulates nutraceutical and wellness products.
- Markets and sells nutraceutical products in the United States.
- Distributes nutraceuticals to mass retailers, specialty stores, and distributors.
Business Model
- Cultivation and extraction of cannabinoids for sale to manufacturers and distributors.
- Manufacturing and sale of cannabinoid-based products to consumers and businesses.
- Formulation, manufacturing, and sale of nutraceutical and wellness products in the U.S.
- Distribution through mass retailers, specialty stores, and distributors.
Industry Context
Clever Leaves operates within the rapidly expanding cannabis and nutraceutical industries. The global cannabis market is projected to reach billions of dollars in the coming years, driven by increasing legalization and acceptance of cannabis for medicinal and recreational purposes. The nutraceuticals market is also experiencing growth, fueled by rising consumer awareness of health and wellness. However, both industries are highly competitive and subject to evolving regulations. Clever Leaves competes with other cannabis producers and nutraceutical companies, facing challenges related to market access, product differentiation, and regulatory compliance.
Key Customers
- Cannabis product manufacturers and distributors.
- Consumers seeking cannabinoid-based products.
- Mass retailers in the United States.
- Specialty and health retailers in the United States.
Financials
Chart & Info
Clever Leaves Holdings Inc. (CLVR) stock price: Price data unavailable
Latest News
-
Earnings Scheduled For August 14, 2023
benzinga · Aug 14, 2023
-
Stocks That Hit 52-Week Lows On Wednesday
benzinga · Apr 26, 2023
-
Stocks That Hit 52-Week Lows On Tuesday
benzinga · Oct 11, 2022
-
Stocks That Hit 52-Week Lows On Monday
benzinga · Oct 10, 2022
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CLVR.
Price Targets
Wall Street price target analysis for CLVR.
MoonshotScore
What does this score mean?
The MoonshotScore rates CLVR's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Andres Fajardo
Unknown
Information about Andres Fajardo's specific background and career history is not available in the provided data. Therefore, a detailed biography cannot be provided. His professional experience and educational background are unknown.
Track Record: Specific achievements and strategic decisions made by Andres Fajardo as CEO of Clever Leaves Holdings Inc. are not detailed in the provided data. Therefore, a comprehensive track record cannot be assessed.
CLVR OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Clever Leaves may not meet the minimum financial standards or reporting requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and performance compared to companies listed on major exchanges like the NYSE or NASDAQ. Trading on the OTC Other tier often implies higher risk and requires increased due diligence.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure.
- Lower trading volume and liquidity.
- Higher price volatility.
- Potential for fraud or manipulation.
- Increased regulatory scrutiny.
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's regulatory compliance and legal risks.
- Monitor the company's news and press releases for any red flags.
- Consult with a financial advisor before investing.
- Understand the risks associated with OTC trading.
- Company has been in operation since 2017.
- Operates in a regulated industry (cannabis and nutraceuticals).
- Has a diversified product portfolio.
- Maintains a physical headquarters in Boca Raton, Florida.
What Investors Ask About Clever Leaves Holdings Inc. (CLVR)
What does Clever Leaves Holdings Inc. do?
Clever Leaves Holdings Inc. operates as a global cannabis company with two segments: Cannabinoid and Non-Cannabinoid. The Cannabinoid segment focuses on the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products internationally. The Non-Cannabinoid segment formulates, manufactures, markets, sells, and distributes nutraceutical and wellness products in the United States. The company aims to leverage its international presence and diversified product portfolio to capture a significant share of the growing cannabis and wellness markets.
What do analysts say about CLVR stock?
AI analysis for CLVR is currently pending. Without analyst consensus or ratings, investors should conduct thorough independent research, considering the company's financial performance, market position, and risk factors. Key valuation metrics to monitor include revenue growth, gross margin, and profitability. Growth considerations include the expansion of its international cannabinoid operations and the growth of its nutraceutical business in the U.S. Investors should also carefully consider the company's OTC market listing and associated risks.
What are the main risks for CLVR?
Clever Leaves faces several key risks, including the evolving and uncertain regulatory landscape in the cannabis industry, intense competition in both the cannabis and nutraceutical markets, fluctuations in commodity prices, and the potential for product recalls or liability claims. The company's OTC market listing also raises concerns about liquidity and access to capital. Investors should carefully consider these risks before investing in Clever Leaves.
How does Clever Leaves Holdings Inc. navigate regulatory approval processes?
As a cannabis company, Clever Leaves Holdings Inc. faces complex regulatory approval processes in various jurisdictions. The company must comply with regulations related to cultivation, extraction, manufacturing, and distribution of cannabis products. Specific details regarding Clever Leaves' FDA/EMA regulatory track record, pending approvals, and compliance strategy are not available in the provided data. However, the company's ability to navigate these regulatory hurdles will be crucial for its long-term success.
How does Clever Leaves Holdings Inc. manage its supply chain for cannabis production?
Managing the supply chain is critical for Clever Leaves to ensure consistent product quality and availability. This includes sourcing raw materials, managing cultivation and extraction processes, and ensuring efficient distribution. Specific details about Clever Leaves' supply chain management practices are not available in the provided data. However, the company's ability to effectively manage its supply chain will be essential for maintaining its competitive advantage and meeting customer demand.
What are the key factors to evaluate for CLVR?
Clever Leaves Holdings Inc. (CLVR) currently holds an AI score of 47/100, indicating low score. Key strength: Diversified product portfolio (cannabinoid and non-cannabinoid).. Primary risk to monitor: Ongoing: Evolving and uncertain regulatory landscape in the cannabis industry.. This is not financial advice.
How frequently does CLVR data refresh on this page?
CLVR prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven CLVR's recent stock price performance?
Recent price movement in Clever Leaves Holdings Inc. (CLVR) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Diversified product portfolio (cannabinoid and non-cannabinoid).. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is limited to the provided data.
- AI analysis is pending, which could provide further insights.